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Introduction
Ca2+ is the most abundant cation in the human body
and serves a number of important physiological func-
tions, including fertilization, synaptic transmission,
muscle contraction, blood clotting, and bone mineral-
ization. The extracellular Ca2+ concentration is con-
trolled by the kidney, intestine, and bone through the
action of the calciotropic hormones, including parathy-
roid hormone (PTH) and 1,25-dihydroxycholecalcifer-
ol (1,25-(OH)2D3). In humans, the daily dietary Ca2+
intake is less than 1,000 mg, of which only 30% is
absorbed in the intestinal tract. This percentage is sig-
nificantly enhanced during growth, pregnancy, and lac-
tation by increased levels of circulating 1,25-(OH)2D3.
Although there is continuous turnover of bone mass,
there is no net gain or loss of Ca2+ from bone in a young
and healthy individual. This indicates that healthy
adults excrete a maximum of 300 mg Ca2+ in the urine
to balance the intestinal Ca2+ uptake and that the
remaining 98% of the Ca2+ filtered in the glomeruli is
reabsorbed along the nephron. The molecular mecha-
nism responsible for Ca2+ absorption in the small intes-
tine and the kidney was elusive for a long time.
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Ca2+ ions play a fundamental role in many cellular processes, and the extracellular concentration
of Ca2+ is kept under strict control to allow the proper physiological functions to take place. The
kidney, small intestine, and bone determine the Ca2+ flux to the extracellular Ca2+ pool in a con-
certed fashion. Transient receptor potential (TRP) cation channel subfamily V, members 5 and 6
(TRPV5 and TRPV6) have recently been postulated to be the molecular gatekeepers facilitating
Ca2+ influx in these tissues and are members of the TRP family, which mediates diverse biologi-
cal effects ranging from pain perception to male aggression. Genetic ablation of TRPV5 in the
mouse allowed us to investigate the function of this novel Ca2+ channel in maintaining the Ca2+
balance. Here, we demonstrate that mice lacking TRPV5 display diminished active Ca2+ reab-
sorption despite enhanced vitamin D levels, causing severe hypercalciuria. In vivo micropuncture
experiments demonstrated that Ca2+ reabsorption was malfunctioning within the early part of the
distal convolution, exactly where TRPV5 is localized. In addition, compensatory hyperabsorption
of dietary Ca2+ was measured in TRPV5 knockout mice. Furthermore, the knockout mice exhib-
ited significant disturbances in bone structure, including reduced trabecular and cortical bone
thickness. These data demonstrate the key function of TRPV5 in active Ca2+ reabsorption and its
essential role in the Ca2+ homeostasis.
J. Clin. Invest. 112:1906–1914 (2003). doi:10.1172/JCI200319826.
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The cloning of transient receptor potential (TRP)
cation channel subfamily V, member 5 (TRPV5; origi-
nally called ECaC1) from vitamin D–responsive rabbit
renal epithelial cells (1) and TRP cation channel sub-
family V, member 6 (TRPV6; originally called CaT1)
from rat duodenum (2) has ignited research into tran-
scellular Ca2+ (re)absorption at the molecular level (1).
Mammals harbor at least 21 genes of the so-called TRP
channels, whose functions remain mostly unknown
(3). TRPV5 has been implicated as the Ca2+ influx chan-
nel in the process of vitamin D–responsive active Ca2+
reabsorption in the kidney (1, 4). In comparison, the
TRPV5 homolog TRPV6, which displays an amino acid
sequence identity of about 75% to TRPV5, has been
postulated to be the Ca2+ influx channel facilitating
Ca2+ absorption in enterocytes (2). TRPV6 is ubiqui-
tously expressed and has been implicated as part of the
capacitative Ca2+ entry mechanism and, therefore,
intracellular Ca2+ signaling (5). TRPV5 and TRPV6 are
Ca2+-selective channels that belong, together with the
temperature-activated vanilloid receptors, to the TRPV
subfamily (3, 4). Genomic cloning has demonstrated
that TRPV5 and TRPV6 form a unique pair of novel
Ca2+ channels that are transcribed from distinct genes
juxtaposed on human chromosome 7q35 (4).
The present study investigated the physiological
function of TRPV5 by the generation and characteri-
zation of TRPV5 knockout mice. Here, we demonstrate
that the new TRP member TRPV5 is the gatekeeper in
active Ca2+ reabsorption in the kidney. Ablation of the
TRPV5 gene seriously disturbs renal Ca2+ handling,
resulting in compensatory intestinal hyperabsorption
and bone abnormalities.
Methods
Generation of TRPV5-null mice. The TRPV5 gene was
cloned from a 129/Sv mouse genomic library. For
TRPV5 gene information, see GenBank accession
number AF336378. The following fragments were then
subcloned into a modified lox-targeting vector con-
taining three loxP sites (6). First, a 1.2-kb 5′ homology
fragment was inserted upstream of the 5′ loxP site in
the pAT-FRT- K13 plasmid (kindly provided by A.
Trumpp, University of California at San Francisco, San
Francisco, California, USA) using long-range PCR with
Takara polymerase (Takara Biomedical, Tokyo, Japan).
For 3′ homology, a PCR-amplified 4-kb fragment was
subcloned in the PmeI site of the pBS KS(+) targeting
vector adjacent to the negative selection gene HSV-Tk
(kindly provided by F. Radtke, University of Lausanne).
Subsequently, for the functional channel region, a
600-bp PCR fragment containing exon 13 encoding
the entire pore-forming region of the TRPV5 protein
was cloned into the NotI and AscI sites by exchange of
the neomycin-flanked loxP cassette. Finally, these two
vectors were combined to construct the neomycin-
loxP–targeting vector. To this end, the XhoI–NotI frag-
ment from the pAT-FRT-K13 plasmid, containing the
5′ homology, the frt-flanked neomycin cassette, and
the 5′ loxP site, was cloned into the SalI and NotI site of
the pBS KS(+) vector upstream of the vital region. Elec-
troporation and selection of targeted clones has been
described (7). A recombinant ES cell was used to gen-
erate chimeras, allowing germline transmission of the
mutant allele (TRPV5loxneo). Heterozygous mice
(TRPV5+/–) harboring a null allele were obtained by
breeding TRPV5loxneo mice with a germline EIIa-cre-
deletor strain (8). Offspring of heterozygous null
mutants were subsequently intercrossed to obtain the
TRPV5+/+, TRPV5+/–, and TRPV5–/– mice used in this
study. The frt-flanked neomycin cassette was not delet-
ed in these mice. In all experiments, B6.129TRPV5–/–,N2
mice were compared with their TRPV5+/+ and TRPV5+/–
littermates. Adult mice 8–9 weeks old, fed ad libitum,
were placed in metabolic cages for 48 hours (Techni-
plast, Buguggiate, Italy). Food and fluid intake was
monitored by weighing “sipper” bottles before and
after the test period. Mice were allowed to adapt to
these cages for 1 day, and then 24-hour urine samples
were collected. The animal ethics board of the Univer-
sity Medical Center Nijmegen approved all experi-
mental procedures.
Genotyping. Genotyping was confirmed by Southern
blot analysis of tail-derived DNA digested with BamHI
and hybridized to a 5′ probe that demonstrated suc-
cessful generation of the TRPV5loxneo and TRPV5null
alleles (Figure 1, a and b). Heterozygous mice harbor
a band of 5.8 kb plus a 4.6-kb endogenous wild-type
band. Subsequently, genotypes were determined by
PCR with primers A (5′-GCCAAGTTCTAATTCCATCA-
GAAG-3′) and B (5′-CTCCTATTCCCTGAAACCGCA-3′) to
detect the null allele; and C (5′-TTCCCCAACT-
GTTCTTCCTGG-3′) and D (5′-AGATCCTCCAGTGTCT-
CATGCT-3′) to detect the wild-type allele (Figure 1a).
The presence or absence of a 500-bp fragment (null
allele) or 483-bp fragment (wild-type allele) identifies
animals with –/–, +/+, and +/– genotypes (Figure 1c).
Serum and urine analysis. Serum 1,25-(OH)2D3, PTH,
osteocalcin concentrations, and alkaline phosphatase
were assayed according standard procedures. Mouse
serum PTH levels were measured using a kit from
Immunotopics Inc. (San Clemente, California, USA).
Deoxypyrillinodine was analyzed in urine (Biometra, San
Francisco, USA). Electrolytes in urine were measured
using an Autoanalyzer (Hitachi, Laval, Quebec, Canada).
Micropuncture. Mice anesthetized by inactin/ketamine
were prepared for micropuncture as described (9). For
assessment of GFR of both kidneys and of single
nephrons, [3H]inulin was infused intravenously. Urine
was collected using a bladder catheter. The left kidney
was prepared for micropuncture. On the kidney surface,
the last loop of proximal tubules (LPTs) or the distal
convolutions were identified and punctured for quan-
titative collection of tubular fluid. Tubular fluid vol-
ume was determined from column length in a constant
bore capillary. The tubular fluid concentration of K+
was determined by a micro-flame photometer (Depart-
ment of Pharmacology, University of Tübingen) (9) and
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of Ca2+, by a flow-through microfluorometer (NanoFlo;
WPI, Sarasota, Florida, USA) using Fluo-3 (MoBiTec,
Göttingen, Germany) for detection (10, 11).
Immunohistochemistry. Antibodies against TRPV5 and
TRPV6 were obtained by immunization of guinea pigs
and rabbits, respectively, with channel-specific peptides
as described previously (12). Kidneys from TRPV5+/+ and
TRPV5–/– mice were cut into pieces, placed in 1%
(weight/volume) periodate-lysine-paraformaldehyde
fixative for 2 hours, and incubated overnight in phos-
phate-buffered saline containing 15% (weight/volume)
sucrose. Subsequently, samples were frozen in liquid
nitrogen and sections 5–7 µm in thickness were used for
different staining procedures as described previously
(12). Rabbit anti-kallikrein was purchased from Cal-
biochem (San Diego, California, USA). All negative con-
trols, including sections incubated with preimmune
serum, subjected to preabsorption for 1 hour with 10
µg/ml TRPV5 or TRPV6 peptide, or incubated solely
with conjugated secondary antibodies, were devoid of
any staining. Photographs were taken with a Bio-Rad
MRC 1000 confocal laser-scanning microscope.
Quantitative real-time PCR analysis. Total RNA was
extracted from kidney and duodenal tissues using the
TriZol Total RNA Isolation Reagent (Gibco BRL, Breda,
The Netherlands). The RNA was subjected to DNAse
treatment to prevent genomic DNA contamination.
Thereafter, 2 µg RNA was reverse-transcribed by
Moloney murine leukemia virus reverse transcriptase
(Gibco BRL) as described previously (13). The cDNA
obtained was used to determine TRPV6, calbindin-D28K,
calbindin-D9K, and NCX1 mRNA expression levels, as
well as mRNA levels of the housekeeping gene hypox-
anthine-guanine phosphoribosyl transferase (HPRT) as
an endogenous control, as described previously (13).
Expression levels were quantified by real-time quantita-
tive PCR on an ABI Prism 7700 Sequence Detection Sys-
tem (PE Biosystems, Rotkreuz, Switzerland).
In vivo 45Ca2+ absorption assay. Ca2+ absorption was
assessed by measuring serum 45Ca2+ at early time points
after oral gavage. Mice were fasted 12 hours before the
test. Animals were hemodynamically stable under anes-
thesia (urethane, 1.4 mg/g body weight) during the
experiment. The solution used to measure Ca2+ absorp-
tion contained 0.1 mM CaCl2, 125 mM NaCl, 17 mM
Tris, and 1.8 g/l fructose and was enriched with 20 µCi
45CaCl2/ml (18 Ci/g; New England Nuclear, Newton,
Massachusetts, USA). For the oral tests, 15 µl/g body
Figure 1
Creation of null mutant mice for the TRPV5 gene locus. (a) Targeted inactivation of the TRPV5 gene. Top, exon 13, encoding the pore-form-
ing unit of TRPV5, is flanked by loxP sites. Middle, recombined TRPV5loxneo locus. Bottom, targeted allele in which exon 13 is deleted by Cre
recombinase. Black boxes indicate exons; probe and genotype primers (A–D) are depicted. neoR, neomycin resistance cassette. (b) Repre-
sentative Southern blot analysis of BamHI-digested tail-derived DNA isolated from TRPV5+/+, TRPV5+/–, and TRPV5–/– mice. (c) Identification
of mouse genotype by PCR analysis of tail-derived DNA. The PCR product in the upper gel shows the presence of the wild-type allele (+/+)
using primers C and D; the lower gel shows the knockout allele (–/–) using primers A and B. Both alleles are detected in heterozygous ani-
mals (+/–). (d) TRPV5 (top images) and kallikrein (lower images) immunohistochemical costaining of kidney cortex from TRPV5+/+ and
TRPV5–/– mice. (e) Immunopositive TRPV6 staining of renal distal tubules from TRPV5+/+ and TRPV5–/– mice. A color version of this figure is
available online as Supplementary Figure 1 (http://www.jci.org/cgi/content/full/112/12/1906/DC1).
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weight of this solution was administrated by gavage as
described previously (14). Blood samples were obtained
at indicated time intervals (Figure 3c). Serum (10 µl)
was analyzed by liquid scintillation counting. The
change in the plasma Ca2+ concentration was calculat-
ed from the 45Ca2+ content of the plasma samples and
the specific activity of the administrated Ca2+.
Bone analysis. Femurs from 8- to 9-week-old TRPV5+/+
mice (females, n = 9; males, n = 5) and TRPV5–/– mice
(females, n = 8; males, n = 5) were scanned using the
SkyScan 1072 microtomograph (SkyScan, Antwerp,
Belgium). Scans were processed and a three-dimen-
sional morphometric analysis of the bone was per-
formed, using free software of the 3D-Calculator proj-
ect (http://www.eur.nl/fgg/orthopaedics/Downloads.
html). Measured parameters were expressed according
to bone histomorphometry nomenclature (15). In the
femoral head, bone volume (BV), total bone marrow
volume including trabeculae (TV), trabecular bone vol-
ume fraction (BV/TV), trabecular thickness (Tb.Th)
(16), trabecular number (Tb.N) (16), connectivity den-
sity (CD) (measure of the interconnectivity of the tra-
becular network; ref 17), and structure model index
(SMI) (predominance of the shape of the trabeculae;
0 = plate-like; 3 = rod-like; ref. 18) were determined. In
the diaphysis, calculations were performed with regard
to cortical volume (Ct.V), endocortical volume (Ec.V),
total diaphyseal volume (Dp.V) (sum of Ct.V and
Ec.V), cortical thickness (Ct.Th) and cortical bone vol-
ume fraction (Ct.V/Dp.V) (16), and moment of inertia
(MOI) (measure of the geometrical distribution
indicative of the mechanical strength per transversal
cross-section). Dissected femurs were routinely
processed for plastic embedding. “Plastified” bone sec-
tions were deacrylated and rehydrated. Tartrate-resist-
ant acid phosphatase (TRAP) staining was used to
specifically stain osteoclasts red, as described (19). The
number and surface area of osteoclasts per bone sur-
face area (N.Oc/BS and Oc.S/BS, respectively) were
determined in the femoral metaphysis using the Bio-
quant Novoprime digital-imaging software (Bioquant,
Nashville, Tennessee, USA).
Statistics. Data are expressed as means ± SEM. Statis-
tical comparisons were tested by one-way analysis of
variance (ANOVA). P values less than 0.05 were consid-
ered statistically significant. All analyses were per-
formed using the StatView Statistical Package software
(Power PC version 4.51; Berkeley, California, USA) on a
Macintosh computer.
Results and Discussion
Genetic ablation of TRPV5 in the mouse allowed us to
investigate the requirement of TRPV5 functioning in
maintaining the Ca2+ balance. The conditional target-
ing strategy was aimed at deleting the functionally
critical region of the protein that encodes exon 13,
comprising the entire pore region, using Cre-loxP–
mediated recombination (Figure 1a). This procedure
will allow the engineering of tissue-specific TRPV5
knockout mice strains in the near future, but in the
present study TRPV5 null allele mutants were gener-
ated to address the overall function of this channel. To
this end, TRPV5loxneo/+ and EIIa-cre transgenic mice
were crossed (8). The murine TRPV5 gene is encoded
by 15 exons and spans about 15 kb (GenBank acces-
sion number, AF336378). Southern blot together with
PCR analysis demonstrated the deletion of pore-
encoding exon 13, as shown in Figure 1, b and c. Im-
munohistochemical costaining of kidney cortex using
antibodies against TRPV5 and kallikrein, a specific
maker for distal convolution that comprises distal
convoluted and connecting tubules (20), confirmed
that the mutant TRPV5 allele was inactivated (Figure
1d). Importantly, ablation of the TRPV5 locus did not
affect renal TRPV6 expression, confirming the gene-
specific inactivation of TRPV5 (Figure 1e).
Gross observation revealed no obvious phenotype
in the TRPV5-null mice. TRPV5–/– and TRPV5+/– mice
were fertile and had similar average litter sizes (Fig-
ure 2a). TRPV5–/– pups nursed without aid and
thrived to adulthood at a rate similar to that of wild-
type mice, as assessed by size and weight at sexual
maturity. TRPV5–/– females displayed normal mater-
nal behaviors such as crouching and nursing, and
Figure 2
Phenotypic characterization of TRPV5 knockout
mice. (a) Body weights at an age of 8 weeks of
TRPV5+/+, TRPV5+/–, and TRPV5–/– mice (n = 29–43
mice). (b) The 24-hour urine volumes obtained
from mice maintained in metabolic cages (n = 9
mice, three mice per cage). (c) Analysis of pH of
urine obtained from TRPV5+/+, TRPV5+/–, and
TRPV5–/– mice (n = 9 mice, three mice per cage).
(d) Total excretion of Ca2+, Na+, and K+ in
TRPV5+/+, TRPV5+/–, and TRPV5–/– mice (n = 9 mice,
three mice per cage). Of note, TRPV5+/– mice were
similar to TRPV5+/+ mice for the parameters meas-
ured. Data are averaged values ± SEM from mice
at an age of 8 weeks. *P < 0.05, significant differ-
ence from TRPV5+/+ mice.
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transfer of a nursing female to a new cage initiated
nest-building activity and efficient pup retrieval.
TRPV5+/+, TRPV5+/–, and TRPV5–/– mice were housed
for 48 hours in metabolic cages (three mice per cage),
and urine and serum samples were collected to investi-
gate whether the electrolyte metabolism was disturbed.
Polyuria was consistently observed in TRPV5–/– mice
compared with heterozygous mutants and wild-type
littermates (Figure 2b). Importantly, TRPV5–/– mice dis-
played a significant calciuresis, as they excreted about
six times more Ca2+ in their urine than did their
TRPV5+/+ and TRPV5+/– littermates (Figure 2d, left
panel). The urinary Ca2+ concentration of the knockout
mice reached values as high as 20 mM, compared with
6 mM for TRPV5+/+ littermates. In addition, urinary
phosphate excretion was significantly increased in
TRPV5–/– mice compared with that of TRPV5+/+ mice
(512 ± 30 µmol and 327 ± 25 µmol per 24 hours per
three mice, respectively; n = 6, P < 0.05). Polyuria facili-
tates the excretion of large quantities of Ca2+ by reduc-
ing the potential risk of Ca2+ precipitation. It has been
demonstrated that a high luminal Ca2+ concentration
activates the calcium-sensing receptor in the apical
membrane of the inner medullary collecting duct. As a
consequence, the arginine vasopressin–elicited (AVP-
elicited) water permeability is blunted to prevent a fur-
ther rise in urinary Ca2+ concentration and possibly
stone formation (21). Hypercalciuria-induced polyuria
has been observed in humans and animal models
(22–24). Notably, TRPV5–/– mice produced urine that
was significantly more acidic than that of their
TRPV5+/+ and TRPV5+/– littermates (Figure 2c). Acidifi-
cation of the urine is known to prevent renal stone for-
mation in hypercalciuria, as Ca2+ oxalate stones cannot
be formed at a pH of 5–6 (25). Neutralization of the
acidic urine obtained from TRPV5–/– mice resulted in
the development of large crystals, confirming that acid-
ification of the urine of the knockout mice is crucial for
the prevention of kidney stone formation. A better
understanding of the molecular mechanism by which
hypercalciuria occurs will be important for the devel-
opment of clinical tools that may lead to screening of
families of “stone formers” before the onset of overt
disease and to early treatment.
A primary renal origin of the observed calciuresis was
supported by the fact that hypercalciuria persisted
when TRPV5–/– mice consumed a Ca2+-deficient diet for
1 week (data not shown). Furthermore, the GFR was
not different between TRPV5–/– and TRPV5+/+ mice
(0.31 ± 0.01 ml/min and 0.30 ± 0.07 ml/min, respec-
tively; n = 6), indicating a primary defect in renal Ca2+
reabsorption as the cause of calciuresis in TRPV5–/– mice.
Figure 3
Renal and duodenal Ca2+ transport assays. (a) Fractional Ca2+ delivery to the LPT, to the distal convolution (DC), and to urine (U), meas-
ured by micropuncture experiments in TRPV5+/+ and TRPV5–/– mice. (b) Relation between K+ concentration in tubular fluid of the distal con-
volution and fractional Ca2+ delivery to these sites. Low K+ concentrations indicate early puncture sites and high K+ concentrations late aspects
of distal convolution (2). Values are means ± SEM of six mice per group for urine data and of 19–24 nephrons per group for LPT and distal
convolution collections. *P < 0.05 versus TRPV5+/+. (c) Changes in serum Ca2+ (∆µM) within 10 minutes of administration of 45Ca2+ by oral
gavage in TRPV5+/+ and TRPV5–/– mice (n = 12). Data are averaged values ± SEM from mice 8 weeks old. *P < 0.05, significant difference
from wild-type mice. (d) Expression of calbindin-D28K and NCX1 mRNA in kidney cortexes of TRPV5+/+ and TRPV5–/– mice (n = 9), assessed
by quantitative real-time PCR analysis and calculated as a ratio to HPRT RNA. (e) Expression of TRPV6 and calbindin-D9K mRNA in duo-
denums of TRPV5+/+ and TRPV5–/– mice, assessed by quantitative real-time PCR analysis and calculated as a ratio to the HPRT RNA (n = 9). 
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To localize the site of defective Ca2+ reabsorption along
the nephron, we performed micropuncture studies
(9–11) in anesthetized TRPV5–/– and TRPV5+/+ mice
(Figure 3a). Confirming the results of the experiments
in the metabolic cages, TRPV5–/– mice showed calciure-
sis as a consequence of reduced renal Ca2+ reabsorp-
tion. Quantitative free-flow collection of tubular fluid
revealed unaffected Ca2+ reabsorption in TRPV5–/– mice
up to the LPT. In contrast, mean Ca2+ delivery to punc-
turing sites within the distal convolution was signifi-
cantly enhanced in TRPV5–/– mice.
Because K+ secretion occurs along the distal nephron
sites accessible to micropuncture (together with water
reabsorption in the connecting tubule and cortical col-
lecting duct), the distal luminal [K+] was used as an
indicator of the distal collection site (Figure 3b). Based
on the shape of the relationship between distal luminal
[K+] and fractional Ca2+ delivery, it is evident that, in
TRPV5–/– mice, in contrast to TRPV5+/+ mice, fraction-
al Ca2+ delivery increases with higher [K+], indicating a
defect in Ca2+ reabsorption along the distal convolu-
tion, which is consistent with the expression site of
TRPV5. Given the potential internephron variations,
the observation that some nephrons of TRPV5–/– mice
with low luminal [K+] exhibit low and some high frac-
tional Ca2+ delivery is consistent with a rapid increase
in luminal Ca2+ delivery along the early distal convolu-
tions of mice lacking TRPV5. The increase in mean
fractional Ca2+ delivery with increasing luminal [K+] in
TRPV5–/– mice cannot be explained by a simple lack of
Ca2+ reabsorption, but would be consistent with Ca2+
back-leak into the lumen in the absence of transcellu-
lar reabsorption. In comparison, if the primary Ca2+
reabsorption defect were upstream of the distal convo-
lution, for example, in the thick limb of Henle’s loop,
then fractional Ca2+ delivery should be enhanced in
TRPV5–/– mice distal nephrons irrespective of the lumi-
nal [K+]. This contrasts with the observation made in
the TRPV5–/– mice, indicating that the transport defect
is localized primarily in the distal convolution. The frac-
tional delivery of Na+ to the distal convolution was not
significantly different between TRPV5–/– and TRPV5+/+
mice (4 ± 1% vs. 5 ± 1%, respectively; n = 6, P > 0.2),
which argues against the idea that a primary decrease
in Na+ reabsorption upstream of the distal convolution
indirectly influences Ca2+ reabsorption.
In the Ca2+-reabsorbing epithelial cells of the distal
convolution, the influx of Ca2+ is rapidly buffered by
cytosolic calcium-binding proteins, that is, calbindin-
D28K and calbindin-D9K, and the bound Ca2+ diffuses to
the basolateral membrane where a Na+-Ca2+ exchanger
(NCX1) and, to a lesser extent, an ATP-dependent Ca2+
Figure 4
Bone phenotypes of female and male TRPV5+/+ and TRPV5–/– mice. (a) Representative cross-sectional x-ray images of the femoral head (I),
the lesser trochanter (II), and the diaphysis (III) in TRPV5+/+ and TRPV5–/– mice. Note the decreased cortical bone width in the trochanter
and diaphysis (arrows). (b) MOI as a parameter of bone quality. (c) Three-dimensional reconstruction of femurs from TRPV5+/+ and
TRPV5–/– mice. Note the reduced cortical and Tb.Th in TRPV5–/– mice. (d) Changes in serum levels of 1,25-(OH)2D3, PTH, and Ca2+ in
TRPV5+/+, TRPV5+/–, and TRPV5–/– mice. Values are expressed as percentage of TRPV5+/+ values ± SEM. The absolute values for PTH are
TRPV5+/+, 55 ± 15 pg/ml; TRPV5+/–, 59 ± 14 pg/ml; and TRPV5–/–, 60 ± 16 pg/ml; for 1,25-(OH)2D3, TRPV5+/+, 239 ± 38 pmol/l; TRPV5+/–,
225 ± 32 pmol/l; TRPV5–/–, 691 ± 88 pmol/l; and for free Ca2+ concentration, TRPV5+/+, 1.20 ± 0.02 mM; TRPV5+/–, 1.25 ± 0.03 mM; and
TRPV5–/–, 1.20 ± 0.03 mM. *P < 0.05, significant difference from wild-type mice.
 
Downloaded from http://www.jci.org on February  1, 2016.   http://dx.doi.org/10.1172/JCI19826
1912 The Journal of Clinical Investigation | December 2003 | Volume 112 | Number 12
pump extrude Ca2+ to the blood compartment, com-
pleting the process of transcellular Ca2+ transport (4).
The expression of the Ca2+ transport proteins in the
kidney was investigated by quantitative real-time PCR
as described previously (13). Inactivation of the TRPV5
gene was accompanied by a decrease in calbindin-D28K
and NCX1 mRNA levels (Figure 3d). As transcellular
Ca2+ reabsorption in the distal convolution was abol-
ished in TRPV5–/– mice, the concomitant decrease in
calbindin-D28K and NCX1 mRNA levels in the presence
of elevated 1,25-(OH)2D3 levels suggests a regulatory
mechanism controlled primarily by TRPV5. Thus,
TRPV5 or the Ca2+ influx through TRPV5 possibly con-
trols the transcription of the other Ca2+ transport
genes, including calbindin-D28K and NCX1. These find-
ings emphasize the gatekeeper function of TRPV5.
Although downregulation of renal calbindin-D28K is
secondary to TRPV5 ablation in the TRPV5–/– mice, the
reduced calbindin-D28K level may further augment the
severity of the hypercalciuria. Interestingly, calbindin-
D28K knockout mice fed a Ca2+ diet (1% weight/volume)
displayed an approximately twofold increase in urinary
Ca2+ excretion compared with that of their wild-type lit-
termates (26), whereas TRPV5–/– mice fed the same Ca2+
diet excreted about six times more Ca2+ in their urine
than did their littermates.
In contrast to the excessive renal Ca2+ wasting noted,
natriuresis and kaliuresis were not observed in the
knockout mice, demonstrating the specific effect of
TRPV5 inactivation on Ca2+ reabsorption (Figure 2d).
Importantly, despite renal Ca2+ wasting, the serum Ca2+
concentration remained normal, suggesting successful
compensatory mechanisms (Figure 4d). We investigat-
ed whether the impairment of transcellular Ca2+ reab-
sorption indirectly affected intestinal Ca2+ absorption.
Active Ca2+ uptake by the small intestine is favored as
compensation for renal Ca2+ wasting. To provide func-
tional evidence for intestinal hyperabsorption in
TRPV5–/– mice, we assessed Ca2+ absorption by measur-
ing serum 45Ca2+ at early time points after oral gavage,
as described (14). A significant increase in the rate
45Ca2+ absorption was observed in TRPV5–/– mice com-
pared with their wild-type littermates, indicating a
compensatory role for the small intestine (Figure 3c).
Of note, this may actually represent an underestima-
tion due to the applied single-45Ca2+-isotope technique
used instead of a dual-isotope technique (27). Whereas
TRPV5 is expressed predominantly in the kidney,
TRPV6 is highly expressed in small intestine and has
been implicated as the Ca2+ influx mechanism in ente-
rocytes (1, 2). To test this hypothesis, duodenal RNA
was extracted from knockout and wild-type littermates
and analyzed for expression of TRPV6 and calbindin-
D9K by quantitative real-time PCR analysis. TRPV6 and
calbindin-D9K expression levels were significantly
upregulated in TRPV5–/– mice, consistent with an
increased Ca2+ absorption (Figure 3, c and e).
Serum 1,25-(OH)2D3 levels were significantly ele-
vated in TRPV5–/– mice (Figure 4d), which explains
the compensatory increased intestinal TRPV6 and
calbindin-D9K mRNA expression and Ca2+ absorp-
tion. The TRPV5–/– mouse is the first model to our
knowledge to have sustained highly elevated 1,25-
(OH)2D3 levels while remaining normocalcemic (Fig-
ure 4d) and normophosphatemic, as serum phos-
phate was not different between the TRPV5+/+ and
TRPV5–/– mice (2.68 ± 0.29 and 3.04 ± 0.18 mM,
respectively, n = 6, P > 0.2). The elevated 1,25-(OH)2D3
Table 1
Bone analysis of TRPV5+/+ and TRPV5–/– mice
Females Males
+/+ –/– +/+ –/–
Femoral head BV/TV (%) 20.1 ± 1.96 17.7 ± 1.00 24.7 ± 1.13 24.0 ± 1.09
Tb.Th (µm) 71.1 ± 1.2 63.8 ± 1.6A 73.9 ± 1.7 66.5 ± 1.5A
Tb.N 283 ± 23.8 277 ± 13.5 362 ± 22.4 333 ± 10.4
CD (mm–3) 0.16 ± 0.02 0.16 ± 0.02 0.24 ± 0.04 0.26 ± 0.03
SMI 1.87 ± 0.09 1.99 ± 0.07 1.72 ± 0.05 1.74 ± 0.06
Diaphysis Ct.V (mm3) 2.35 ± 0.13 1.97 ± 0.10A 2.58 ± 0.10 2.22 ± 0.12A
Ec.V (mm3) 1.70 ± 0.09 1.76 ± 0.11 1.85 ± 0.15 1.89 ± 0.13
Dp.V (mm3) 4.05 ± 0.18 3.73 ± 0.19 4.41 ± 0.19 4.10 ± 0.19
Ct.V/Dp.V (%) 58.5 ± 1.40 53.8 ± 0.99A 60.0 ± 1.65 57.1 ± 3.22
Ct.Th (µm) 275 ± 11.1 225 ± 5.6A 266 ± 6.7 231 ± 12.7A
MOI (mm4) 0.41 ± 0.09 0.34 ± 0.09A 0.49 ± 0.10 0.42 ± 0.09A
TRAP staining N.Oc/BS (no./mm) 2.69 ± 0.21 4.37 ± 0.31A 2.62 ± 0.05 3.55 ± 0.49
Oc.S/BS (%) 11.0 ± 1.03 15.6 ± 0.81A 10.5 ± 1.37 12.3 ± 1.19
Serum values OC (ng/ml) 126 ± 12 155 ± 10A 100 ± 9 131 ± 11A
ALP (nmol/min/ml) 225 ± 20 227 ± 14 205 ± 15 248 ± 23
Microcomputed tomography measurements in the femoral head (trabecular bone) and the diaphysis (cortical bone) of TRPV5+/+ and TRPV5–/– mice as
well as measurements deduced from TRAP staining of bone sections and serum values of osteocalcin (OC) and alkaline phosphatase (ALP). Values are
expressed as means ± SEM. AP < 0.05, significant difference between TRPV5+/+ and TRPV5–/– mice, irrespective of sex (general linear regression model)
(SPSS 10.0; SPSS Inc., Chicago, Illinois, USA).
 
Downloaded from http://www.jci.org on February  1, 2016.   http://dx.doi.org/10.1172/JCI19826
The Journal of Clinical Investigation | December 2003 | Volume 112 | Number 12 1913
levels observed in vitamin D receptor (VDR)-null
mice (14) and in rickets type II are normally accom-
panied by hypocalcemia and increased serum PTH
levels. In contrast, in TRPV5–/– mice with normal
functioning VDRs, PTH was not significantly
changed (Figure 4d). The elevated 1,25-(OH)2D3 lev-
els in TRPV5–/– mice were not due to increased expres-
sion of renal 25-hydroxyvitamin D3-1α-hydroxylase
mRNA, since no differences were measured in the
expression of this enzyme between TRPV5+/+ and
TRPV5–/– mice (100 ± 13% and 139 ± 29%, respective-
ly; n = 4, P > 0.2). Studies to clarify the role of 1,25-
(OH)2D3 in bone have been hampered by the com-
plexity of distinguishing between disturbances in
Ca2+ homeostasis and changes in serum 1,25-(OH)2D3
levels. Normal PTH plus normocalcemia make the
TRPV5–/– mouse a unique model to study the effect of
1,25-(OH)2D3 on bone.
The homeostasis of bone tissue is maintained by the
balanced processes of bone resorption and formation.
The bone formation marker alkaline phosphatase was
not different between the groups (Table 1), while osteo-
calcin was slightly but significantly higher in sera of
TRPV5–/– versus TRPV5+/+ mice. Bone resorption was
studied by TRAP staining of femoral bone sections, by
measurement of osteoclast number and surface, and by
measurement of urinary deoxypyridinoline. Both
N.Oc/BS and Oc.S/BS were significantly increased in
female TRPV5–/– mice, with males showing a similar
trend (Table 1). Urinary deoxypyridinoline showed
large variations and was not significantly different
between TRPV5–/– and TRPV5+/+ mice (66 ± 8 nmol/
nmol creatinine and 92 ± 21 nmol/nmol creatinine,
respectively; n = 5–9, P > 0.2).
Detailed microcomputed tomography analyses of
the femur demonstrated that Tb.Th in the femoral
head of TRPV5–/– mice was significantly reduced com-
pared with that of TRPV5+/+ mice (Table 1 and Figure
4, a and c). BV/TV was not different between the geno-
types. This could not be explained by a difference in
Tb.N (Table 1). Alternatively, it is possible that the tra-
beculae are longer, that is, they protrude further into
the bone marrow cavity, and thereby compensate for
reduced Tb.Th. CD and SMI were not altered in the
femoral head, irrespective of phenotype and sex.
Analyses of the diaphysis showed that Ct.V, Ct.V/
Dp.V, and Ct.Th were significantly reduced in
TRPV5–/– versus TRPV5+/+ mice (Table 1 and Figure 4,
a and c). Finally, the polar MOI was significantly
reduced in TRPV5–/– mice, indicative of an altered geo-
metrical distribution and reduced mechanical prop-
erties of the diaphyseal bone (Table 1 and Figure 4b).
The observed changes in bone structure cannot be
attributed to differences in body weight (Figure 2a).
Also, the bone lengths of TRPV5–/– and TRPV5+/+ mice
were similar. In summary, the unchanged alkaline
phosphatase together with the elevated N.Oc/BS and
Oc.S/BS in the TRPV5–/– mice may explain the
observed reduced trabecular and cortical thickness.
It is unclear whether the reduced Tb.Th and Ct.Th
found in the TRPV5–/– mice is a direct effect of the
genotype or results from prolonged elevated 1,25-
(OH)2D3 levels. Interestingly, a recent study of long-
term treatment of mice with 1,25-(OH)2D3 demon-
strated a decrease in cortical thickness and cross-
sectional area and a 50% reduction in stiffness (28),
which is in line with the current observations. We
hypothesize that the bone phenotype of the TRPV5–/–
mice, due to prolonged elevated 1,25-(OH)2D3 levels,
develops and progresses throughout life. However, at
present it is premature to draw definitive conclusions
about bone metabolism, and future experiments will
certainly address this point in detail.
The epithelial Ca2+ channels TRPV5 and TRPV6
have been studied extensively in epithelial tissues
controlling the Ca2+ homeostasis and exhibit a range
of distinctive properties that distinguish them from
other TRP channels (3, 4). TRP channels display an
extraordinary assortment of selectivities and activa-
tion mechanisms, some of which represent previous-
ly unrecognized modes for regulating ion channels
(3). Moreover, there is only limited information
about the biological functions of TRP channels,
which appear to be equally diverse and range from
pain perception to male aggression. The present
study demonstrated that the new TRP member
TRPV5 is the gatekeeper in active Ca2+ reabsorption
in the kidney. Ablation of the TRPV5 gene seriously
disturbs renal Ca2+ handling, resulting in compensa-
tory intestinal hyperabsorption and bone abnormal-
ities. These deficiencies in Ca2+ handling have been
reported frequently in patients with idiopathic
hypercalciuria, although the molecular basis for this
disorder remains unknown. Dysfunction of TRPV5
may contribute to such disturbances of Ca2+ home-
ostasis, and the TRPV5 knockout mouse is, therefore,
a powerful animal model for elucidating the molecu-
lar mechanism underlying idiopathic hypercalciuria.
Finally, the increased 1,25-(OH)2D3 levels and effects
on bone structure indicate that alterations in TRPV5
may have implications for age-related bone disorders,
including osteoporosis.
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